Rankings
▼
Calendar
ARCT Q3 2023 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena
ARCT
Arcturus Therapeutics Holdings Inc.
$217M
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$43M
+224.5% YoY
Gross Profit
$43M
100.0% margin
Operating Income
-$19M
-44.5% margin
Net Income
-$16M
-37.4% margin
EPS (Diluted)
$-0.61
QoQ Revenue Growth
+312.4%
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$33M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$458M
Total Liabilities
$178M
Stockholders' Equity
$280M
Cash & Equivalents
$312M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$43M
$13M
+224.5%
Gross Profit
$43M
-$24M
+278.4%
Operating Income
-$19M
-$37M
+47.5%
Net Income
-$16M
-$35M
+54.0%
← FY 2023
All Quarters
Q4 2023 →